scispace - formally typeset
Journal ArticleDOI

Antidepressants for the new millennium.

Phil Skolnick
- 30 Jun 1999 - 
- Vol. 375, Iss: 1, pp 31-40
TLDR
It is hypothesized that two different treatment strategies converge to produce an identical functional endpoint: a region-specific dampening of NMDA receptor function, providing a rudimentary framework for discovering novel antidepressants.
About
This article is published in European Journal of Pharmacology.The article was published on 1999-06-30. It has received 367 citations till now. The article focuses on the topics: Antidepressant & Serotonin.

read more

Citations
More filters
Journal ArticleDOI

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

TL;DR: Robust and rapid antidepressant effects resulted from a single intravenous dose of an N-methyl-D-aspartate antagonist; onset occurred within 2 hours postinfusion and continued to remain significant for 1 week.
Journal ArticleDOI

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

TL;DR: A paradigm shift from a monoamine hypothesis of depression to a neuroplasticity hypothesis focused on glutamate may represent a substantial advancement in the working hypothesis that drives research for new drugs and therapies.
Journal ArticleDOI

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

TL;DR: Preclinical studies have shown that critical molecules in neurotrophic signaling cascades are long-term targets for antidepressant agents and antidepressant potentiating modalities, suggesting that effective treatments provide both trophic and neurochemical support, which serves to enhance and maintain normal synaptic connectivity.
Journal ArticleDOI

Glutamate and Depression

TL;DR: Recent data indicate that a single intravenous dose of an NMDA receptor antagonist is sufficient to produce sustained relief from depressive symptoms, and represent exciting and novel avenues to both understand depressive symptomatology and develop more effective antidepressants.
References
More filters
Journal ArticleDOI

Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain Reaction

TL;DR: A method to separate and clone individual messenger RNAs (mRNAs) by means of the polymerase chain reaction using a set of oligonucleotide primers, one being anchored to the polyadenylate tail of a subset of mRNAs, the other being short and arbitrary in sequence so that it anneals at different positions relative to the first primer.
Journal ArticleDOI

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

TL;DR: These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.
Journal ArticleDOI

Recent advances in the phencyclidine model of schizophrenia.

TL;DR: It was found that PCP-induced psychotomimetic effects are associated with submicromolar serum concentrations of PCP and the findings suggest that endogenous dysfunction of NMDA receptor-mediated neurotransmission might contribute to the pathogenesis of schizophrenia.
Journal ArticleDOI

Regulation of BDNF and trkB mRNA in Rat Brain by Chronic Electroconvulsive Seizure and Antidepressant Drug Treatments

TL;DR: The enhanced induction and prolonged expression of BDNF in response to chronic ECS and antidepressant drug treatments could promote neuronal survival, and protect neurons from the damaging effects of stress.
Related Papers (5)